Clopidogrel tapering as a strategy to attenuate platelet rebound phenomenon in patients with bare-metal stents

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 1, 2012, Pages 16-21

  Yedidya, Idit ^a,b   Netzer, Adi ^a,b   Vaduganathan, Muthiah ^a,c   Solodky, Alejandro ^a,b   Kornowski, Ran ^a,b   Lev, Eli I ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antiplatelet therapy; Percutaneous coronary intervention; Platelet function

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; COLLAGEN;

ADULT; AGED; ARTICLE; BARE METAL STENT; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REBOUND; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; TURBIDIMETRY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PROSPECTIVE STUDIES; STENTS; TICLOPIDINE;

EID: 84858860225     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0652-z     Document Type: Article

References (17)

1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502 (Pubitemid 32758501)
2. Steinhubl SR, Berger PB, Mann JT 3rd et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411-2420 (Pubitemid 35340537)
3. Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J AmColl Cardiol 50:e1-e157
4. Kushner FG, Hand M, Smith SC Jr et al (2009) 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54:2205-2241
5. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) ACC/ AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 47:216-235 (Pubitemid 43005194)
6. Ho PM, Peterson ED, Wang L et al (2008) Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 299:532-539 (Pubitemid 351222546)
7. Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126-2130 (Pubitemid 40617065)
8. Jeremias A, Sylvia B, Bridges J et al (2004) Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109:1930-1932 (Pubitemid 38544480)
9. Spertus JA, Kettelkamp R, Vance C et al (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113:2803-2809 (Pubitemid 44305292)
10. Valgimigli M, Campo G, Arcozzi C et al (2007) Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol 50:138-145 (Pubitemid 47002182)
11. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al (2006) Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 55:780-784 (Pubitemid 43343236)
12. Buonamici P, Marcucci R, Migliorini A et al (2007) Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49:2312-2317 (Pubitemid 46891710)
13. Hochholzer W, Trenk D, Bestehorn HP et al (2006) Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48:1742-1750 (Pubitemid 44648629)
14. Sibbing D, Stegherr J, Braun S et al (2010) A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment. J Am Coll Cardiol 55:558-565
15. Geraghty OC, Paul NL, Chandratheva A, Rothwell PM (2010) Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke. Neurology 74:1891-1896
16. Trenk D, Hochholzer W, Fromm MF et al (2008) Cytochrome P450 2C19 681G > A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1 year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 51:1925-1934 (Pubitemid 351636443)
17. Savi P, Pereillo JM, Uzabiaga MF et al (2000) Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 84:891-896